How medical school students are choosing their own oaths

While today’s physicians normally don’t swear to Apollo like in the original Hippocratic oath, even more modern versions are falling out of fashion, with some medical schools letting students craft their own vow to “do no harm.”

STAT News found several schools where the traditional oath is being replaced. At the University of Texas’ new Dell Medical School, the inaugural class selected its own version, choosing to modify a 1964 oath written by a former dean of the Tufts University School of Medicine used by around 33 percent of medical schools.

“I will remember that I do not treat a fever chart, or a cancerous growth, but a sick human being,” read one part of the oath.

Other oaths reflect values of the particular institution, like at California’s Loma Linda University, where medical students do make a pledge to God while foregoing the original oath’s swearing off of abortion and euthanasia.

Harvard Medical School allows each class of students to craft their oaths both at the white coat ceremony and graduation. The latest edition included parts that STAT’s Melissa Bailey said sounds “like a fiery sermon.”

“We promise to bear witness to historical injustices that continue to unfold for marginalized communities,” the oath reads. “We must have the courage to act when we witness injustice.”

For more on the wide variety of oaths at different medical schools, click on the link below:  

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.